PentaBind
PrivateLast Round
Grant
Jul 1, 2024
Total Funding Raised
$260,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
PentaBind operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Grant round in July 2024.
PentaBind is a biotechnology company that develops precision aptamer therapeutics intended to treat unmet diseases. The company uses artificial intelligence and an integrated wet laboratory to design aptamers that can be used to detect and target almost any molecule of interest, with an initial focus on oncology.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PentaBind Comparables
Compare PentaBind with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Atom Bioworks | 84% | |
| AlhenaBio Limited | 79% | |
| Neoncorte Bio | 79% |
For institutional investors. Book with your work email.
PentaBind Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 1, 2024 | ||||
| Pre Seed | Jan 11, 2024 | ||||
| Accelerator | Oct 1, 2023 | ||||
| Accelerator | Dec 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
PentaBind Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KQ Labs | Accelerator, Pre Seed |
| Hoxton Ventures | Pre Seed |
| Panacea Stars | Accelerator |
| Innovate UK | Grant |
| The Francis Crick Institute | Accelerator |
| LifeArc | Accelerator |
| Next Sequence | Pre Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 240% MoM, reaching 1.6K.
- Sep 27, 2024
Grew 67% QoQ, from 6 to 10 employees.
For institutional investors. Book with your work email.
PentaBind Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PentaBind's valuation, stock price, and market status.
Is PentaBind a public or private company?
PentaBind is a private company.
What is the current stock price of PentaBind?
PentaBind is a private company, so its shares have no public market price. Caplight tracks PentaBind's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PentaBind worth (valuation)?
Valuation information for PentaBind is not publicly available.
Can I buy PentaBind stock?
PentaBind shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PentaBind's last funding round?
PentaBind's most recent funding round was Grant on July 1, 2024.
Who are the main investors in PentaBind?
Key investors in PentaBind include KQ Labs, Hoxton Ventures, Panacea Stars, Innovate UK, The Francis Crick Institute.
Will PentaBind IPO soon?
No public IPO plans have been announced for PentaBind.
How can I track PentaBind secondary market activity?
Caplight tracks bids, offers, and trades in PentaBind's shares on secondary markets.